Sequenom, which is developing noninvasive genetic tests for pregnant women, will delay the launch of a product that tests for Down syndrome due to "employee mishandling" of research and development test data and results, it said April 29...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99